Publication | Closed Access

A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption

Primary ImmunodeficiencyHuman RetrovirusImmunologyAntiviral ResponseAutoimmunityChronic Viral InfectionDendritic Cell BiologyHivImmunotherapyMedicinePhase I/iiaAids PathogenesisDendritic CellsTreatment Interruption